(Q33660397)

28 July 2017

title

From Pichia anomala killer toxin through killer antibodies to killer peptides for a comprehensive anti-infective strategy (English)

1 reference

28 July 2017

Pichia anomala

1 reference

Luciano Polonelli

1

1 reference

28 July 2017

Walter Magliani

2

1 reference

28 July 2017

Tecla Ciociola

3

1 reference

28 July 2017

Laura Giovati

4

1 reference

28 July 2017

Stefania Conti

5

1 reference

28 July 2017

language of work or name

1 reference

18 August 2010

1 reference

28 July 2017

number of pages

7

1 reference

based on heuristic

inferred from page(s)

published in

Antonie van Leeuwenhoek

1 reference

28 July 2017

volume

99

1 reference

28 July 2017

issue

1

1 reference

28 July 2017

page(s)

35-41

1 reference

Interplay between protective and inhibitory antibodies dictates the outcome of experimentally disseminated Candidiasis in recipients of a Candida albicans vaccine

28 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS10482-010-9496-3

Protection of killer antiidiotypic antibodies against early invasive aspergillosis in a murine model of allogeneic T-cell-depleted bone marrow transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-010-9496-3

Mycobactericidal activity of human natural, monoclonal, and recombinant yeast killer toxin-like antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-010-9496-3

Therapeutic activity of an anti-idiotypic antibody-derived killer peptide against influenza A virus experimental infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-010-9496-3

Production of an engineered killer peptide in Nicotiana benthamiana by using a potato virus X expression system

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-010-9496-3

In vitro acanthamoebicidal activity of a killer monoclonal antibody and a synthetic peptide.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-010-9496-3

Therapeutic potential of yeast killer toxin-like antibodies and mimotopes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-010-9496-3

Engineered killer mimotopes: new synthetic peptides for antimicrobial therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-010-9496-3

From yeast killer toxins to antibiobodies and beyond

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-010-9496-3

Reversible self-assembly: a key feature for a new class of autodelivering therapeutic peptides.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-010-9496-3

Hansenula anomala killer toxin induces secretion and severe acute injury in the rat intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-010-9496-3

Potential therapeutic effect of yeast killer toxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-010-9496-3

Therapeutic activity of an engineered synthetic killer antiidiotypic antibody fragment against experimental mucosal and systemic candidiasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-010-9496-3

An anti-beta-glucan monoclonal antibody inhibits growth and capsule formation of Cryptococcus neoformans in vitro and exerts therapeutic, anticryptococcal activity in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-010-9496-3

Activity of an engineered synthetic killer peptide on Leishmania major and Leishmania infantum promastigotes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-010-9496-3

A novel glyco-conjugate vaccine against fungal pathogens

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10482-010-9496-3

10.1007/S10482-010-9496-3

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

28 July 2017

1031430318

0 references

1 reference